市場調査レポート
商品コード
1352087

創傷洗浄剤市場- 世界および地域別分析:製品タイプ別、創傷タイプ別、エンドユーザー別、国別分析 - 分析と予測(2023年~2030年)

Wound Cleanser Market - A Global and Regional Analysis: Focus on Product, Wound Type, End User, and Country Analysis - Analysis and Forecast, 2023-2030

出版日: | 発行: BIS Research | ページ情報: 英文 204 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
創傷洗浄剤市場- 世界および地域別分析:製品タイプ別、創傷タイプ別、エンドユーザー別、国別分析 - 分析と予測(2023年~2030年)
出版日: 2023年09月15日
発行: BIS Research
ページ情報: 英文 204 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創傷洗浄剤の市場規模は、2022年に18億7,340万米ドルとなりました。

同市場は、2023年から2030年にかけて3.34%のCAGRで拡大し、2030年には24億3,430万米ドルに達すると予測されています。世界の創傷洗浄剤市場の成長を促進する主な要因には、創傷洗浄剤の利用増加につながる慢性疾患の有病率の上昇、外科手術や外傷の症例数の増加、創傷洗浄剤製品の受け入れと利用の増加、創傷感染症の有病率の上昇、高度な創傷ケア製品の需要を生み出す創傷ケア専門クリニックの増加などがあります。

主要市場統計
Forecast Period2023 - 2030
2023 の評価19億3,410万米ドル
2030 の予測24億3,430万米ドル
CAGR3.34%

創傷洗浄剤は、創傷の洗浄と灌流を目的とした溶液や製品のタイプです。創傷の適切な治癒を促進し、感染を予防し、創傷全体の衛生状態を維持するために、創傷ケア管理の一環として使用されます。創傷洗浄剤市場は、創傷の洗浄と消毒に使用される製品を指します。これらの製品は通常、創傷の洗浄と、ドレッシング材の適用や縫合などのさらなる医療処置の準備に使用されます。創傷洗浄剤市場には、創傷に付着したゴミ、細菌、その他の汚染物質を除去して治癒を促進し、感染リスクを低減するように設計された様々な製品が含まれます。

2022年のアジア太平洋の創傷洗浄剤市場は、中国が33.15%のシェアを占めました。この成長を後押ししている要因には、創傷回復用製品に対する需要の増加、慢性創傷の発生率の上昇、地域全体での外科手術件数の増加などがあります。中国では糖尿病の流行が大きな特徴となっており、糖尿病患者の治癒遅延リスクに対処する創傷洗浄剤市場の必要性が高まっています。

慢性疾患の増加は創傷感染の増加につながります。慢性疾患は世界規模で急速に増加しており、全世界の死亡原因の63%を占めています。これらの病気は米国だけでも約1億3,300万人に影響を及ぼしており、これは全人口の40%以上に相当します。2020年の予測はさらに重大で、罹患者は約1億5,700万人に増加すると予想され、そのかなりの部分が複数の疾患を抱えています。

個人の健康と清潔志向の高まりにより、創傷洗浄用製品を求める人が急増しています。健康に対する意識が高まり、健康維持のために行動するようになり、医師に相談する時期も早まっています。治りの早い傷も、長引く傷も、早めにケアすることが、より良く、より早く治すために重要です。健康情報を読み、理解することを学ぶ人が増えるにつれ、家庭で小さな怪我に対処する方法を知る人も増えています。

当レポートでは、世界の創傷洗浄剤市場について調査し、市場の概要とともに、製品タイプ別、創傷タイプ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場

  • 世界市場の展望

第2章 業界の展望

  • 主要な動向
  • 機会の評価
  • 価格分析
  • サプライチェーン分析

第3章 COVID-19の影響

第4章 ビジネスダイナミクス

  • 影響分析
  • ビジネスの促進要因
  • ビジネスの抑制要因
  • ビジネスの機会

第5章 製品

  • 機会の評価
  • 成長シェアマトリックス
  • 業務用クレンザー
  • 生理食塩水

第6章 創傷タイプ

  • 機会の評価
  • 成長シェアマトリックス
  • 慢性創傷
  • 急性創傷

第7章 エンドユーザー

  • 機会の評価
  • 成長シェアマトリックス
  • 病院
  • 専門クリニック
  • 在宅ヘルスケア(OTC)

第8章 地域

  • 北米の創傷洗浄剤市場
  • 欧州の創傷洗浄剤市場
  • アジア太平洋の創傷洗浄剤市場
  • ラテンアメリカの創傷洗浄剤市場
  • その他の地域の創傷洗浄剤市場

第9章 市場-競合ベンチマーキングと企業プロファイル

  • 市場シェア分析
  • 活躍企業のエコシステム
  • 企業プロファイル
    • 3M
    • ACTO GmbH
    • Argentum Medical, LLC
    • B. Braun S.E.
    • Bactiguard AB
    • Coloplast Group
    • Cardinal Health, Inc.
    • Gentell, Inc.
    • Hollister Incorporated
    • Medline Industries, LP
    • Molnlycke Health Care AB
    • Schulke & Mayr GmbH
    • Smith & Nephew
    • Sonoma Pharmaceuticals, Inc.
    • Sanara Medtech, Inc.
    • Urgo Medical
図表

List of Figures

  • Figure 1: Wound Cleanser Applications
  • Figure 2: Number of Wound Care Centers in Different Economies
  • Figure 3: Global Wound Cleanser Market, $Million, 2021-2030
  • Figure 4: Global Wound Cleanser Market, Market Dynamics
  • Figure 5: Key Trends in the Global Wound Cleanser Market
  • Figure 6: Global Wound Cleanser Market Share (by Product), 2022 and 2030
  • Figure 7: Global Wound Cleanser Market Share (by End User), 2022 and 2030
  • Figure 8: Global Wound Cleanser Market Share (by Wound Type), 2022 and 2030
  • Figure 9: Global Wound Cleanser Market (by Region), $Million, 2022
  • Figure 10: Global Wound Cleanser Market Segmentation
  • Figure 11: Global Wound Cleanser Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Global Wound Cleanser Market, Key Trends
  • Figure 16: Global Wound Cleanser Market, Key Trends, Opportunity Assessment, 2023-2030
  • Figure 17: Factors Influencing Pricing of Advanced Wound Care Products
  • Figure 18: Global Wound Cleanser Market, Supply Chain Analysis
  • Figure 19: Global Wound Cleanser Market, Impact Analysis
  • Figure 20: Burden of the Diabetic Foot
  • Figure 21: Ideal Properties of a Wound Cleanser
  • Figure 22: Some of the Wound Cleansers, Globally
  • Figure 23: Factors Acting as a Restraining Factor for the Adoption of Wound Cleansers
  • Figure 24: Global Wound Cleanser Market (by Product)
  • Figure 25: Global Wound Cleanser Market, Incremental Opportunity (by Product), $Million, 2023-2030
  • Figure 26: Global Wound Cleanser Market, Growth-Share Matrix (by Product), 2023-2030
  • Figure 27: Global Wound Cleanser Market (Commercial Cleanser), $Million, 2021-2030
  • Figure 28: Commercial Wound Cleanser Market (by End User), $Million, 2021-2030
  • Figure 29: Commercial Wound Cleanser Market (by Format Type), $Million, 2021-2030
  • Figure 30: Global Wound Cleanser Market (Saline), $Million, 2021-2030
  • Figure 31: Saline Wound Cleanser Market (by End User), $Million, 2021-2030
  • Figure 32: Global Wound Cleanser Market (by Wound Type)
  • Figure 33: Global Wound Cleanser Market, Incremental Opportunity (by Wound Type), $Million, 2023-2030
  • Figure 34: Global Wound Cleanser Market, Growth-Share Matrix (by Wound Type), 2023-2030
  • Figure 35: Global Wound Cleanser Market (Chronic Wound), $Million, 2021-2030
  • Figure 36: Global Wound Cleanser Market (Acute Wound), $Million, 2021-2030
  • Figure 37: Global Wound Cleanser Market (by End User)
  • Figure 38: Global Wound Cleanser Market, Incremental Opportunity (by End User), $Million, 2023-2030
  • Figure 39: Global Wound Cleanser Market, Growth-Share Matrix (by End User), 2023-2030
  • Figure 40: Global Wound Cleanser Market (Hospitals), $Million, 2021-2030
  • Figure 41: Global Wound Cleanser Market (Speciality Clinics), $Million, 2021-2030
  • Figure 42: Global Wound Cleanser Market (Home Healthcare (Over the Counter (OTC)), $Million, 2021-2030
  • Figure 43: Global Wound Cleanser Market Share (by Region), 2021-2030
  • Figure 44: Medical Device Classification, U.S. FDA
  • Figure 45: North America Wound Cleanser Market, Incremental Opportunity (by Country), $Million, 2023-2030
  • Figure 46: North America Wound Cleanser Market, $Million, 2021-2030
  • Figure 47: North America Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 48: North America Wound Cleanser Market (by Country), % Share, 2022 and 2030
  • Figure 49: U.S. Wound Cleanser Market, $Million, 2021-2030
  • Figure 50: Canada Wound Cleanser Market, $Million, 2021-2030
  • Figure 51: Europe Wound Cleanser Market, $Million, 2021-2030
  • Figure 52: Europe Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 53: Germany Wound Cleanser Market, $Million, 2021-2030
  • Figure 54: U.K. Wound Cleanser Market, $Million, 2021-2030
  • Figure 55: France Wound Cleanser Market, $Million, 2021-2030
  • Figure 56: Italy Wound Cleanser Market, $Million, 2021-2030
  • Figure 57: Spain Wound Cleanser Market, $Million, 2021-2030
  • Figure 58: Portugal Wound Cleanser Market, $Million, 2021-2030
  • Figure 59: Netherlands Wound Cleanser Market, $Million, 2021-2030
  • Figure 60: Ireland Wound Cleanser Market, $Million, 2021-2030
  • Figure 61: Belgium Wound Cleanser Market, $Million, 2021-2030
  • Figure 62: Switzerland Wound Cleanser Market, $Million, 2021-2030
  • Figure 63: Norway Wound Cleanser Market, $Million, 2021-2030
  • Figure 64: Denmark Wound Cleanser Market, $Million, 2021-2030
  • Figure 65: Sweden Wound Cleanser Market, $Million, 2021-2030
  • Figure 66: Finland Wound Cleanser Market, $Million, 2021-2030
  • Figure 67: Czech Republic Wound Cleanser Market, $Million, 2021-2030
  • Figure 68: Russian Federation Wound Cleanser Market, $Million, 2021-2030
  • Figure 69: Poland Wound Cleanser Market, $Million, 2021-2030
  • Figure 70: Austria Wound Cleanser Market, $Million, 2021-2030
  • Figure 71: Romania Wound Cleanser Market, $Million, 2021-2030
  • Figure 72: Slovakia Wound Cleanser Market, $Million, 2021-2030
  • Figure 73: Greece Wound Cleanser Market, $Million, 2021-2030
  • Figure 74: Turkey Wound Cleanser Market, $Million, 2021-2030
  • Figure 75: Ukraine Wound Cleanser Market, $Million, 2021-2030
  • Figure 76: Regulatory Pathway for Wound Cleansers in Japan
  • Figure 77: Asia-Pacific Wound Cleanser Market, Incremental Opportunity (by Country), $Million, 2023-2030
  • Figure 78: Asia-Pacific Wound Cleanser Market, $Million, 2021-2030
  • Figure 79: Asia-Pacific Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 80: Asia-Pacific Wound Cleanser Market (by Country), % Share, 2022 and 2030
  • Figure 81: China Wound Cleanser Market, $Million, 2021-2030
  • Figure 82: Japan Wound Cleanser Market, $Million, 2021-2030
  • Figure 83: India Wound Cleanser Market, $Million, 2021-2030
  • Figure 84: Australia Wound Cleanser Market, $Million, 2021-2030
  • Figure 85: South Korea Wound Cleanser Market, $Million, 2021-2030
  • Figure 86: Thailand Wound Cleanser Market, $Million, 2021-2030
  • Figure 87: Malaysia Wound Cleanser Market, $Million, 2021-2030
  • Figure 88: Rest-of-Asia-Pacific Wound Cleanser Market, $Million, 2021-2030
  • Figure 89: Latin America Wound Cleanser Market, Incremental Opportunity (by Country), $Million, 2023-2030
  • Figure 90: Latin America Wound Cleanser Market, $Million, 2021-2030
  • Figure 91: Latin America Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 92: Latin America Wound Cleanser Market (by Country), % Share, 2022 and 2030
  • Figure 93: Brazil Wound Cleanser Market, $Million, 2021-2030
  • Figure 94: Argentina Wound Cleanser Market, $Million, 2021-2030
  • Figure 95: Chile Wound Cleanser Market, $Million, 2021-2030
  • Figure 96: Colombia Wound Cleanser Market, $Million, 2021-2030
  • Figure 97: Rest-of-Latin America Wound Cleanser Market, $Million, 2021-2030
  • Figure 98: Rest-of-the-World Wound Cleanser Market, $Million, 2021-2030
  • Figure 99: Rest-of-the-World Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 100: Global Wound Cleanser Market, Company Revenue Share Analysis, $Billion, 2022
  • Figure 101: 3M: Product Portfolio
  • Figure 102: 3M: Overall Financials 2020-2022
  • Figure 103: 3M: Net Revenue (by Business Segment), $Million, 2020-2022
  • Figure 104: 3M: Net Revenue (by Geography), $Million, 2020-2020
  • Figure 105: ACTO GmbH: Product Portfolio
  • Figure 106: Argentum Medical, LLC: Product Portfolio
  • Figure 107: B. Braun S.E.: Product Portfolio
  • Figure 108: B. Braun S.E.: Overall Financials, 2020-2022
  • Figure 109: Bactiguard AB: Product Portfolio
  • Figure 110: Bactiguard AB: Overall Financials, 2020-2022
  • Figure 111: Coloplast Group: Product Portfolio
  • Figure 112: Coloplast Group: Overall Financials, 2020-2022
  • Figure 113: Coloplast Group: Net Revenue (by Business Segment), $Million, 2020-2022
  • Figure 114: Coloplast Group: Net Revenue (by Region), $Million, 2020-2022
  • Figure 115: Coloplast Group: R&D Expenditure, $Million, 2020-2022
  • Figure 116: Cardinal Health, Inc.: Product Portfolio
  • Figure 117: Cardinal Health, Inc.: Overall Financials, 2020-2022
  • Figure 118: Cardinal Health, Inc.: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 119: Cardinal Health, Inc.: Net Revenue (by Country), $Million, 2020-2022
  • Figure 120: Gentell, Inc: Product Portfolio
  • Figure 121: Hollister Incorporated: Product Portfolio
  • Figure 122: Medline Industries, LP: Product Portfolio
  • Figure 123: Molnlycke Health Care AB: Product Portfolio
  • Figure 124: Molnlycke Health Care AB: Overall Financials, 2020-2022
  • Figure 125: Molnlycke Health Care AB: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 126: Molnlycke Health Care AB: Net Revenue (by Country), $Million, 2020-2022
  • Figure 127: Molnlycke Health Care AB: Net Revenue (by Channel), $Million, 2020-2022
  • Figure 128: Schulke & Mayr GmbH: Product Portfolio
  • Figure 129: Smith & Nephew: Product Portfolio
  • Figure 130: Smith & Nephew: Overall Financials, 2020-2022
  • Figure 131: Smith & Nephew: Net Revenue (by Business Segment), $Million, 2020-2022
  • Figure 132: Smith & Nephew: Net Revenue (by Advanced Wound Management), $Million, 2020-2022
  • Figure 133: Smith & Nephew: Net Revenue (by Region), $Million, 2020-2022
  • Figure 134: Sonoma Pharmaceuticals, Inc.: Product Portfolio
  • Figure 135: Sonoma Pharmaceuticals, Inc.: Overall Financials, 2021-2023
  • Figure 136: Sonoma Pharmaceuticals, Inc.: Net Revenue (by Business Segment), $Million, 2021-2023
  • Figure 137: Sonoma Pharmaceuticals, Inc.: Net Revenue (by Country), $Million, 2021-2023
  • Figure 138: Sanara Medtech, Inc.: Product Portfolio
  • Figure 139: Sanara Medtech, Inc.: Overall Financials, 2020-2022
  • Figure 140: Sanara Medtech Inc.: R&D Expenditure, $Million, 2020-2022
  • Figure 141: Urgo Medical: Product Portfolio

List of Tables

  • Table 1: Key Questions Answered in the Report
  • Table 2: Some of the Wound Cleansers, Pricing
  • Table 3: North America Wound Cleanser Market, Regulations by Country
  • Table 4: North America Wound Cleanser Market, Impact Analysis
  • Table 5: Europe Wound Cleanser Market, Regulations
  • Table 6: Europe Wound Cleanser Market, Impact Analysis
  • Table 7: Asia-Pacific Wound Cleanser Market, Regulations by Country
  • Table 8: Asia-Pacific Wound Cleanser Market, Impact Analysis
  • Table 9: Latin America Wound Cleanser Market, Regulatory Framework by Countries
  • Table 10: Latin America Wound Cleanser Market, Impact Analysis
  • Table 11: Rest-of-the-World Wound Cleanser Market, Impact Analysis
  • Table 12: Global Wound Cleanser Market, Ecosystem of Active Players
目次
Product Code: BHM0468SB

“Global Wound Cleanser Market to Reach $2,434.3 Million by 2030.”

Intro on Wound Cleanser Market

The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030. The key factors driving the growth of the global wound cleanser market include the increase in prevalence of chronic disease leading to increased utilization of wound cleansers, rising number of surgical and trauma cases, rising acceptance and utilization of wound cleanser products, rise in prevalence of wound infections, a growing number of specialties wound care clinics creating a demand for advanced wound care products.

KEY MARKET STATISTICS
Forecast Period2023 - 2030
2023 Evaluation$1,934.1 Million
2030 Forecast$2,434.3 Million
CAGR3.34%

Market Introduction

A wound cleanser is a type of solution or product designed to clean and irrigate wounds. It is used as part of wound care management to promote proper wound healing, prevent infection, and maintain overall wound hygiene. The wound cleanser market refers to products used for cleaning and disinfecting wounds. These products are typically used to clean and prepare wounds for further medical treatment, such as dressing application or suturing. The wound cleanser market includes a variety of products designed to remove debris, bacteria, and other contaminants from wounds to promote healing and reduce the risk of infection.

Impact

The wound cleanser market has made an impact in the following ways:

  • Improved Wound Care Practices: The introduction of advanced wound cleansers has led to improved wound care practices. These cleansers might offer better solutions for cleaning wounds effectively, reducing the risk of infection, and promoting faster healing.
  • Reduced Infection Rates: Wound cleansers with antimicrobial properties have contributed to reduced infection rates in various healthcare settings. These products could help prevent the growth of bacteria and other pathogens in wounds, minimizing the risk of complications.
  • Faster Healing Times: Innovations in wound cleanser formulations lead to faster wound healing times. These products might facilitate the removal of debris and dead tissue, allowing the body to focus on repairing the wound more efficiently.
  • Increased Patient Comfort: Gentle and effective wound cleansers have improved patient comfort during wound care procedures. Reduced pain and irritation during cleansing would lead to better compliance with treatment regimens.
  • Lower Healthcare Costs: By preventing complications and promoting faster healing, wound cleansers have contributed to lower healthcare costs. Reduced infection rates and shorter hospital stays would lead to financial savings for both patients and healthcare systems.
  • Enhanced Accessibility: Advances in wound cleanser technologies have made these products more accessible to a wider range of healthcare facilities, from hospitals to clinics and even home care settings. This increased accessibility would ensure that patients receive appropriate wound care regardless of their location.
  • Integration of New Technologies: The wound cleanser market may have incorporated new technologies, such as smart wound cleansers that monitor healing progress or offer automated dosing. These innovations could lead to more personalized and effective wound care approaches.
  • Research and Development: Continued growth in the wound cleanser market has encouraged further research and development in wound care products. This might include exploring novel ingredients, formulations, and delivery methods to continually improve outcomes.

Impact of COVID-19

The COVID-19 pandemic has had a multifaceted impact on the wound cleanser market. Shifting healthcare priorities toward managing the pandemic led to delayed wound care and disruptions in supply chains. Hospitals' strain on resources affected wound care services, while telemedicine gained prominence. The pandemic highlighted infection prevention's importance, potentially increasing demand for wound cleansers. Innovations addressed challenges such as delayed healing in COVID-19 survivors. Regulatory changes were introduced for medical product availability. As the world recovers, the wound cleanser market adapts to the pandemic's influence on healthcare delivery, with potential long-term effects on chronic wound care and strategic adjustments in response.

Market Segmentation:

Segmentation 1: by Product

  • Commercial Cleanser
  • Saline

Commercial Cleansers to Occupy the Largest Share in the Global Wound Cleanser Market (by Product)

Commercial Cleanser: Commercial wound cleansers are specially formulated products designed to effectively cleanse wounds and promote a healthy wound-healing environment. These cleansers are available in various formulations and formats, each tailored to address specific wound care needs. They often contain a combination of active ingredients that aid in the removal of debris, bacteria, and contaminants from the wound while supporting the healing process.

Saline: Saline wound cleansers, also known as saline solutions or normal saline, are widely used in wound care for cleansing and irrigating wounds. Saline cleansers consist of a sterile solution of sodium chloride (salt) dissolved in purified water. This isotonic solution closely resembles the body's natural fluids and is commonly used for wound cleansing due to its safety, effectiveness, and gentle nature.

Segmentation 2: by Wound

  • Chronic Wound
  • Acute Wound

Acute Wounds to Dominate the Global Wound Cleanser Market (by Wound Type)

Chronic Wound: Chronic wounds are complex, physiochemically compromised injuries resulting from disruptions in the normal wound-healing process, including cellular interventions. They often arise as complications of chronic diseases such as diabetes, where around 15-25% of individuals with diabetes are at risk of developing chronic wounds such as pressure ulcers or diabetic foot ulcers. Unlike acute wounds that heal predictably, chronic wounds resist healing or lack a predetermined healing timeline. Common examples include contaminated or infected surgical wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and ischemic ulcers.

Acute Wound: An acute wound is a sudden injury to the skin that heals predictably and within an expected timeframe, typically 4-6 weeks, following the normal wound healing process. These wounds are a result of external forces or objects causing a puncture or break in the skin layers. Acute wounds, which occur during the initial phase of healing, have a well-defined healing trajectory. The global incidence of acute wounds is on the rise, with over 60% of cases reported in developed regions.

Segmentation 3: by End User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare (Over the Counter (OTC))

Hospitals to Dominate the Global Wound Cleanser Market (by End User)

Based on end users, the hospital segment is expected to register the highest growth among all the end users, which can be attributed to the rise in the geriatric population, increase in public funding, and cost-effectiveness, among others.

Segmentation 4: by Region

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Spain, Italy, Portugal, Netherlands, Ireland, Belgium, Switzerland, Norway, Denmark, Sweden, Finland, Czech Republic, Russian Federation, Poland, Austria, Romania, Slovakia, Greece, Turkey, and Ukraine
  • Asia-Pacific - China, Japan, India, Australia, South Korea, Thailand, Malaysia, and Rest-of-Asia-Pacific
  • Latin America - Brazil, Argentina, Chile, Colombia, and Rest-of-Latin America
  • Rest-of-the-World

China dominated the Asia-Pacific wound cleanser market in 2022 with a share of 33.15%. The factors fueling this growth include the increasing demand for wound recovery products, the rising incidence of chronic wounds, and the escalating number of surgical procedures across the region. The prevalence of diabetes in China is a significant characteristic, leading to an increased necessity for the wound cleanser market to address the risk of delayed healing in diabetic patients. Diabetic patients often experience foot ulcers, a common and disabling complication that can result in leg amputation. In 2021, the International Diabetes Federation (IDF) reported that China had 140.9 million cases of diabetes, accounting for 10.6% of the population. This number is projected to rise by 164.06 million by 2030, with an estimated 72.83 million cases going undiagnosed in 2021. This high incidence of diabetes translates into a significant demand for diabetic foot care management due to the associated rise in diabetic foot ulcers.

Recent Developments in the Wound Cleanser Market

  • In April 2023, Sanara MedTech Inc. announced the receipt of 510(k) clearance for Biasurge advanced surgical solution, which is a patented composition utilizing its Biakos technology. Biasurge has been designed for mechanical cleansing and removal of debris, including microorganisms, from wounds.
  • In January 2023, Sonoma Pharmaceuticals, Inc. announced the distribution and pricing agreement for its Microcyn Rx products, which has been officially granted by the Defense Logistics Agency. This marks a significant milestone as it allows for the distribution of Microcyn Rx products through the DLA's network.
  • In November 2021, Sonoma Pharmaceuticals, Inc. and Dyamed Biotech Pte Ltd. announced an expanded long-term partnership focused on Singapore, Malaysia, Indonesia, and Thailand. This collaboration aims to leverage Sonoma's Microcyn technology, benefiting patients and healthcare providers alike.
  • In March 2021, Sonoma Pharmaceuticals, Inc. announced an agreement with EMC Pharma, LLC, to oversee, promote, and distribute Sonoma's prescription dermatology and eye care products based on HOCl within the U.S. This partnership will be in effect for an initial term of five years, with the possibility of an extension beyond that period.
  • In November 2022, InfuSystem Holdings, Inc. and Sanara MedTech Inc. established a partnership for SI Wound Care, LLC, focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable InfuSystem to offer innovative products, including Cork Medical LLC's negative pressure wound therapy devices and supplies and Sanara's advanced wound care product line to new customers through the jointly controlled entity.
  • In June 2023, the VeriCyn Wound Wash medical device by Armis Biopharma received 510(k) clearance from the FDA for use in cleansing wounds of debris.
  • In April 2023, Convatec acquired technology from the U.K.-based firm 30 Technology, giving rise to conjecture about the timing and method of its integration into Convatec's existing product line.
  • In February 2023, Shore Capital Partners sold Argentum Medical to BioDerm.
  • In May 2023, NovaBay Pharmaceuticals, Inc. reported that China Pioneer Pharma Holdings, Limited had initiated a purchase of NovaBay's NeutroPhase Skin and Wound Cleanser, amounting to $1 million. NovaBay has effectively completed the fulfillment of this order and anticipates recognizing the associated revenue during the second quarter of 2023.
  • In May 2019, Smith & Nephew acquired Osiris Therapeutics, Inc. Osiris Therapeutics, Inc. specializes in the development and promotion of regenerative medicines products for wound care, orthopedics, and sports medicine.
  • In April 2023, Sanara MedTech Inc. received the FDA 510(k) clearance for the advanced surgical solution known as BiaSurges.

Demand - Drivers and Limitations

Market Demand Drivers:

Increase in Prevalence of Chronic Disease Leading to Increase Utilization of Wound Cleansers: An increase in the prevalence of chronic diseases contributes to an increase in wound infections. Chronic diseases have seen a swift rise on a global scale and are accountable for 63% of all worldwide deaths. These diseases impact around 133 million people in the U.S. alone, which is over 40% of the entire population. The projections for 2020 are even more significant, with an expected increase to around 157 million individuals affected, and a substantial portion of them having multiple conditions.

Rising Number of Surgical and Trauma Cases: There is substantial anticipation of a surge in surgical procedures due to improved healthcare accessibility and the expanding elderly demographic. Approximately 313 million surgical procedures are conducted worldwide on an annual basis. There is substantial anticipation of a surge in surgical procedures due to improved healthcare accessibility and the expanding elderly demographic.

Rising Acceptance and Utilization of Wound Cleanser Products: Due to a growing focus on personal health and cleanliness, there's been a huge increase in people wanting products for cleaning wounds. People are more aware of their health and are taking action to stay healthy, even consulting doctors earlier. Taking care of both quick-healing and long-lasting wounds early is important for getting better and faster healing. As more people learn to read and understand health information, they're finding out about ways to handle small injuries at home.

Rise in Prevalence of Wound Infections: Wound infections pose a significant safety risk for both healthcare professionals and patients. Infections arise when wounds are not treated promptly. The initial step in wound care is cleansing the infected area, which significantly aids the healing process. Due to the increasing global patient numbers and population, the demand for wound cleansers is consistently rising. Burn wound infections contribute largely to overall wound infections.

Growing Number of Specialty Wound Care Clinics Creating a Demand for Advanced Wound Care Products: The increasing prevalence of specialty wound care clinics is generating a higher demand for advanced wound care products. These clinics, dedicated to addressing complex and chronic wounds, require specialized products that go beyond traditional wound care solutions. The demand for advanced wound care products is fuelled by the unique needs of these clinics, which often treat patients with hard-to-heal wounds, diabetic ulcers, pressure ulcers, and other challenging conditions.

Market Restraints:

Lack of Medical Education and Awareness: In terms of the financial burden on health and social care providers as well as the effect on patient quality of life (QoL), the presence of a wound is a significant burden. European Wound Management Association advises that people involved in their care and treatment have the necessary knowledge and abilities because the management of chronic wounds is complex and can have a negative impact on patient outcomes.

Lack of Adequate Reimbursement Policies: The lack of adequate reimbursement policies for wound cleansers in healthcare systems can impede patient access, increase costs for individuals, strain healthcare facilities, limit provider choices, stifle innovation, and exacerbate healthcare disparities.

Market Opportunities:

Expansion into Emerging Economies: The expanding wound cleanser market presents significant opportunities in developing nations such as China, India, Brazil, Saudi Arabia, and Singapore. These countries possess substantial potential due to factors such as population growth, unmet medical demands, and increased healthcare expenditure. The rising healthcare spending in the Middle East further enhances the prospects for wound cleanser manufacturers. Additionally, the growth of per capita disposable income is anticipated to contribute to the expansion of the wound cleanser market in these regions.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The global wound cleanser market has been extensively segmented based on various categories, such as products, types, wound types, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled:

  • 3M
  • ACTO GmbH
  • Argentum Medical, LLC
  • B. Braun S.E.
  • Bactiguard AB
  • Coloplast Group
  • Cardinal Health, Inc.
  • Gentell, Inc.
  • Hollister Incorporated
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Schulke & Mayr GmbH
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc.
  • Sanara Medtech, Inc.
  • Urgo Medical

Table of Contents

1 Markets

  • 1.1 Global Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion Criteria
    • 1.1.3 Exclusion Criteria
    • 1.1.4 Overview

2 Industry Outlook

  • 2.1 Key Trends
  • 2.2 Opportunity Assessment
  • 2.3 Price Analysis
  • 2.4 Supply Chain Analysis

3 Impact of COVID-19

  • 3.1 Impact on Overall Market
  • 3.2 Pre-COVID-19
  • 3.3 During COVID-19
  • 3.4 Post COVID-19

4 Business Dynamics

  • 4.1 Impact Analysis
  • 4.2 Business Drivers
    • 4.2.1 Increase in Prevalence of Chronic Disease Leading to Increase Utilization of Wound Cleansers
    • 4.2.2 Rising Number of Surgical and Trauma Cases
    • 4.2.3 Rising Acceptance and Utilization of Wound Cleanser Products
    • 4.2.4 Rise in Prevalence of Wound Infection
    • 4.2.5 Growing Number of Specialty Wound Care Clinics Creating a Demand for Advanced Wound Care Products
  • 4.3 Business Restraints
    • 4.3.1 Lack of Medical Education and Awareness
    • 4.3.2 Lack of Adequate Reimbursement Policies
  • 4.4 Business Opportunities
    • 4.4.1 Expansion into Emerging Economies

5 Products

  • 5.1 Opportunity Assessment
  • 5.2 Growth-Share Matrix
  • 5.3 Commercial Cleanser
    • 5.3.1 Commercial Wound Cleanser Market (by End User)
    • 5.3.2 Commercial Wound Cleanser Market (by Format Type)
  • 5.4 Saline
    • 5.4.1 Saline Wound Cleanser Market (by End User)

6 Wound Type

  • 6.1 Opportunity Assessment
  • 6.2 Growth-Share Matrix
  • 6.3 Chronic Wound
  • 6.4 Acute Wound

7 End User

  • 7.1 Opportunity Assessment
  • 7.2 Growth-Share Matrix
  • 7.3 Hospitals
  • 7.4 Specialty Clinics
  • 7.5 Home Healthcare (Over the Counter (OTC))

8 Regions

  • 8.1 North America Wound Cleanser Market
    • 8.1.1 Legal Framework and Regulatory Requirements
    • 8.1.2 Key Findings and Opportunity Assessment
    • 8.1.3 Market Dynamics
      • 8.1.3.1 Impact Analysis
    • 8.1.4 Market Sizing and Forecast
      • 8.1.4.1 North America Wound Cleanser Market (by Product)
      • 8.1.4.2 North America Wound Cleanser Market (by Country)
        • 8.1.4.2.1 U.S.
          • 8.1.4.2.1.1 Market Dynamics
          • 8.1.4.2.1.2 Market Size and Forecast
        • 8.1.4.2.2 Canada
          • 8.1.4.2.2.1 Market Dynamics
          • 8.1.4.2.2.2 Market Size and Forecast
  • 8.2 Europe Wound Cleanser Market
    • 8.2.1 Legal Framework and Regulatory Requirements
    • 8.2.2 Key Findings and Opportunity Assessment
    • 8.2.3 Market Dynamics
      • 8.2.3.1 Impact Analysis
    • 8.2.4 Market Sizing and Forecast
      • 8.2.4.1 Europe Wound Cleanser Market (by Product)
      • 8.2.4.2 Europe Wound Cleanser Market (by Country)
        • 8.2.4.2.1 Germany
          • 8.2.4.2.1.1 Market Dynamics
          • 8.2.4.2.1.2 Market Size and Forecast
        • 8.2.4.2.2 U.K.
          • 8.2.4.2.2.1 Market Dynamics
          • 8.2.4.2.2.2 Market Size and Forecast
        • 8.2.4.2.3 France
          • 8.2.4.2.3.1 Market Dynamics
          • 8.2.4.2.3.2 Market Size and Forecast
        • 8.2.4.2.4 Italy
          • 8.2.4.2.4.1 Market Dynamics
          • 8.2.4.2.4.2 Market Size and Forecast
        • 8.2.4.2.5 Spain
          • 8.2.4.2.5.1 Market Dynamics
          • 8.2.4.2.5.2 Market Size and Forecast
        • 8.2.4.2.6 Portugal
          • 8.2.4.2.6.1 Market Dynamics
        • 8.2.4.2.7 Market Size and Forecast
        • 8.2.4.2.8 Netherlands
          • 8.2.4.2.8.1 Market Dynamics
          • 8.2.4.2.8.2 Market Size and Forecast
        • 8.2.4.2.9 Ireland
          • 8.2.4.2.9.1 Market Dynamics
          • 8.2.4.2.9.2 Market Size and Forecast
        • 8.2.4.2.10 Belgium
          • 8.2.4.2.10.1 Market Dynamics
          • 8.2.4.2.10.2 Market Size and Forecast
        • 8.2.4.2.11 Switzerland
          • 8.2.4.2.11.1 Market Dynamics
          • 8.2.4.2.11.2 Market Size and Forecast
        • 8.2.4.2.12 Norway
          • 8.2.4.2.12.1 Market Dynamics
          • 8.2.4.2.12.2 Market Size and Forecast
        • 8.2.4.2.13 Denmark
          • 8.2.4.2.13.1 Market Dynamics
          • 8.2.4.2.13.2 Market Size and Forecast
        • 8.2.4.2.14 Sweden
          • 8.2.4.2.14.1 Market Dynamics
          • 8.2.4.2.14.2 Market Size and Forecast
        • 8.2.4.2.15 Finland
          • 8.2.4.2.15.1 Market Dynamics
          • 8.2.4.2.15.2 Market Size and Forecast
        • 8.2.4.2.16 Czech Republic
          • 8.2.4.2.16.1 Market Dynamics
          • 8.2.4.2.16.2 Market Size and Forecast
        • 8.2.4.2.17 Russian Federation
          • 8.2.4.2.17.1 Market Dynamics
          • 8.2.4.2.17.2 Market Size and Forecast
        • 8.2.4.2.18 Poland
          • 8.2.4.2.18.1 Market Dynamics
          • 8.2.4.2.18.2 Market Size and Forecast
        • 8.2.4.2.19 Austria
          • 8.2.4.2.19.1 Market Dynamics
          • 8.2.4.2.19.2 Market Size and Forecast
        • 8.2.4.2.20 Romania
          • 8.2.4.2.20.1 Market Dynamics
          • 8.2.4.2.20.2 Market Size and Forecast
        • 8.2.4.2.21 Slovakia
          • 8.2.4.2.21.1 Market Dynamics
          • 8.2.4.2.21.2 Market Size and Forecast
        • 8.2.4.2.22 Greece
          • 8.2.4.2.22.1 Market Dynamics
          • 8.2.4.2.22.2 Market Size and Forecast
        • 8.2.4.2.23 Turkey
          • 8.2.4.2.23.1 Market Dynamics
          • 8.2.4.2.23.2 Market Size and Forecast
        • 8.2.4.2.24 Ukraine
          • 8.2.4.2.24.1 Market Dynamics
          • 8.2.4.2.24.2 Market Size and Forecast
  • 8.3 Asia-Pacific Wound Cleanser Market
    • 8.3.1 Legal Framework and Regulatory Requirement
    • 8.3.2 Key Findings and Opportunity Assessment
    • 8.3.3 Market Dynamics
      • 8.3.3.1 Impact Analysis
    • 8.3.4 Market Sizing and Forecast
      • 8.3.4.1 Asia-Pacific Wound Cleanser Market (by Product)
      • 8.3.4.2 Asia-Pacific Wound Cleanser Market (by Country)
        • 8.3.4.2.1 China
          • 8.3.4.2.1.1 Market Dynamics
          • 8.3.4.2.1.2 Market Size and Forecast
        • 8.3.4.2.2 Japan
          • 8.3.4.2.2.1 Market Dynamics
          • 8.3.4.2.2.2 Market Size and Forecast
        • 8.3.4.2.3 India
          • 8.3.4.2.3.1 Market Dynamics
          • 8.3.4.2.3.2 Market Size and Forecast
        • 8.3.4.2.4 Australia
          • 8.3.4.2.4.1 Market Dynamics
          • 8.3.4.2.4.2 Market Size and Forecast
        • 8.3.4.2.5 South Korea
          • 8.3.4.2.5.1 Market Dynamics
          • 8.3.4.2.5.2 Market Size and Forecast
        • 8.3.4.2.6 Thailand
          • 8.3.4.2.6.1 Market Dynamics
          • 8.3.4.2.6.2 Market Size and Forecast
        • 8.3.4.2.7 Malaysia
          • 8.3.4.2.7.1 Market Dynamics
          • 8.3.4.2.7.2 Market Size and Forecast
        • 8.3.4.2.8 Rest-of-Asia-Pacific
          • 8.3.4.2.8.1 Market Dynamics
          • 8.3.4.2.8.2 Market Size and Forecast
  • 8.4 Latin America Wound Cleanser Market
    • 8.4.1 Legal Framework and Regulatory Requirement
    • 8.4.2 Key Findings and Opportunity Assessment
    • 8.4.3 Market Dynamics
      • 8.4.3.1 Impact Analysis
    • 8.4.4 Market Sizing and Forecast
      • 8.4.4.1 Latin America Wound Cleanser Market (by Product)
      • 8.4.4.2 Latin America Wound Cleanser Market (by Country)
        • 8.4.4.2.1 Brazil
          • 8.4.4.2.1.1 Market Dynamics
          • 8.4.4.2.1.2 Market Size and Forecast
        • 8.4.4.2.2 Argentina
          • 8.4.4.2.2.1 Market Dynamics
          • 8.4.4.2.2.2 Market Size and Forecast
        • 8.4.4.2.3 Chile
          • 8.4.4.2.3.1 Market Dynamics
          • 8.4.4.2.3.2 Market Size and Forecast
        • 8.4.4.2.4 Colombia
          • 8.4.4.2.4.1 Market Dynamics
          • 8.4.4.2.4.2 Market Size and Forecast
        • 8.4.4.2.5 Rest-of-Latin America
          • 8.4.4.2.5.1 Market Size and Forecast
  • 8.5 Rest-of-the-World Wound Cleanser Market
    • 8.5.1 Key Findings and Opportunity Assessment
    • 8.5.2 Market Dynamics
      • 8.5.2.1 Impact Analysis
    • 8.5.3 Market Sizing and Forecast
      • 8.5.3.1 Rest-of-the-World Wound Cleanser Market (by Product)

9 Markets - Competitive Benchmarking & Company Profiles

  • 9.1 Market Share Analysis
  • 9.2 Ecosystem of Active Players
  • 9.3 Company Profiles
    • 9.3.1 3M
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Role of 3M in the Global Wound Cleanser Market
      • 9.3.1.3 Financials
      • 9.3.1.4 Analyst Perspectives
    • 9.3.2 ACTO GmbH
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Role of ACTO GmbH in the Global Wound Cleanser Market
      • 9.3.2.3 Target Customers
      • 9.3.2.4 Analyst Perspectives
    • 9.3.3 Argentum Medical, LLC
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Role of Argentum Medical, LLC in the Global Wound Cleanser Market
      • 9.3.3.3 Target Customers
      • 9.3.3.4 Analyst Perspectives
    • 9.3.4 B. Braun S.E.
      • 9.3.4.1 Company Overview
      • 9.3.4.2 Role of B. Braun S.E. in the Global Wound Cleanser Market
      • 9.3.4.3 Financials
      • 9.3.4.4 Target Customers
      • 9.3.4.5 Analyst Perspectives
    • 9.3.5 Bactiguard AB
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Role of Bactiguard AB in the Global Wound Cleanser Market
      • 9.3.5.3 Financials
      • 9.3.5.4 Analyst Perspectives
    • 9.3.6 Coloplast Group
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Role of Coloplast Group in the Global Wound Cleanser Market
      • 9.3.6.3 Financials
      • 9.3.6.4 Analyst Perspectives
    • 9.3.7 Cardinal Health, Inc.
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Role of Cardinal Health, Inc. in the Global Wound Cleanser Market
      • 9.3.7.3 Financials
      • 9.3.7.4 Analyst Perspectives
    • 9.3.8 Gentell, Inc.
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Role of Gentell, Inc. in the Global Wound Cleanser Market
      • 9.3.8.3 Target Customers
      • 9.3.8.4 Analyst Perspectives
    • 9.3.9 Hollister Incorporated
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Role of Hollister Incorporated in the Global Wound Cleanser Market
      • 9.3.9.3 Target Customers
      • 9.3.9.4 Analyst Perspectives
    • 9.3.10 Medline Industries, LP
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Role of Medline Industries, LP in the Global Wound Cleanser Market
      • 9.3.10.3 Analyst Perspectives
    • 9.3.11 Molnlycke Health Care AB
      • 9.3.11.1 Company Overview
      • 9.3.11.2 Role of Molnlycke Health Care AB in the Global Wound Cleanser Market
      • 9.3.11.3 Financials
      • 9.3.11.4 Target Customers
      • 9.3.11.5 Analyst Perspectives
    • 9.3.12 Schulke & Mayr GmbH
      • 9.3.12.1 Company Overview
      • 9.3.12.2 Role of Schulke & Mayr GmbH in the Global Wound Cleanser Market
      • 9.3.12.3 Target Customers
      • 9.3.12.4 Analyst Perspectives
    • 9.3.13 Smith & Nephew
      • 9.3.13.1 Company Overview
      • 9.3.13.2 Role of Smith & Nephew in the Global Wound Cleanser Market
      • 9.3.13.3 Financials
      • 9.3.13.4 Recent Developments
      • 9.3.13.5 Target Customers
      • 9.3.13.6 Analyst Perspectives
    • 9.3.14 Sonoma Pharmaceuticals, Inc.
      • 9.3.14.1 Company Overview
      • 9.3.14.2 Role of Sonoma Pharmaceuticals, Inc. in the Global Wound Cleanser Market
      • 9.3.14.3 Financials
      • 9.3.14.4 Recent Developments
      • 9.3.14.5 Target Customers
      • 9.3.14.6 Analyst Perspectives
    • 9.3.15 Sanara Medtech, Inc.
      • 9.3.15.1 Company Overview
      • 9.3.15.2 Role of Sanara Medtech, Inc. in the Global Wound Cleanser Market
      • 9.3.15.3 Financials
      • 9.3.15.4 Recent Developments
      • 9.3.15.5 Analyst Perspectives
    • 9.3.16 Urgo Medical
      • 9.3.16.1 Company Overview
      • 9.3.16.2 Role of Urgo Medical in the Global Wound Cleanser Market
      • 9.3.16.3 Target Customers
      • 9.3.16.4 Analyst Perspectives